Portal de Periódicos da CAPES

Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation

2014; Elsevier BV; Volume: 123; Issue: 23 Linguagem: Inglês

10.1182/blood-2014-01-552984

1528-0020

Philippe Armand, Haesook T. Kim, Brent R. Logan, Zhiwei Wang, Edwin P. Alyea, Matt Kalaycio, Richard T. Maziarz, Joseph H. Antin, Robert J. Soiffer, Daniel J. Weisdorf, J. Douglas Rizzo, Mary M. Horowitz, Wael Saber,

Acute Lymphoblastic Leukemia research

Key Points The DRI successfully stratified patients in a very large allogeneic transplantation registry cohort. The DRI was refined by using this cohort to build a more inclusive and conditioning intensity–independent index.